Streetbeat News

Stock Prices

GOOG

GOOGL

MSFT

Alphabet Inc's shares (GOOG, GOOGL) are trading lower after reports surfaced about the company considering charging for AI-powered search features. This would be a first for Google's core Search product. The potential premium service would include AI enhancements and possibly integrate with Google's existing subscription services. Despite the dip, Alphabet's stock has been viewed positively by analysts, with expectations of growth. Meanwhile, Microsoft Corp (MSFT) has already launched an AI-powered search tool, Copilot, over a year ago.

Portfolio Pulse from Adam Eckert

April 04, 2024 | 1:25 pm

CASA

Casa Systems' shares are trading lower due to ongoing weakness following the company's announcement of filing for Chapter 11 bankruptcy in the U.S. Bankruptcy Court.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 1:24 pm

TLRY

Tilray Brands Inc (NASDAQ:TLRY) shares have surged nearly 75% over the last month, driven by cannabis legalization in Germany, optimism for U.S. rescheduling, and a favorable Florida Supreme Court decision. The company announced new products and 420 celebratory events in Canada, and is set to report Q3 financial results with an expected loss of 5 cents per share and revenue of $198.62 million.

Portfolio Pulse from Adam Eckert

April 04, 2024 | 1:24 pm

LEVI

Levi Strauss & Co (NYSE:LEVI) shares rose in premarket trading after reporting Q1 earnings of 26 cents per share, surpassing analyst estimates of 21 cents. Despite a decline in operating margin and adjusted EBIT margin due to restructuring charges from Project Fuel, the company announced a dividend and raised its FY24 EPS guidance. Sales decreased by 7.76%, but direct-to-consumer revenues grew by 7%. Cash and total liquidity remained strong.

Portfolio Pulse from Nabaparna Bhattacharya

April 04, 2024 | 1:20 pm

EFTR

EFFECTOR Therapeutics announced the primary analysis results of the Phase 2 KICKSTART trial of tomivosertib combined with pembrolizumab in non-small cell lung cancer, leading to a decrease in their share prices.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 1:17 pm

GSK

PFE

SNY

Sanofi SA (NASDAQ:SNY) has reached an agreement in principle to settle around 4,000 U.S. lawsuits related to the heartburn drug Zantac, excluding cases in Delaware. The settlement, terms of which are confidential, comes amid allegations that Zantac could cause cancer due to NDMA, a potential carcinogen. Sanofi maintains no liability admission. The settlement aims to resolve most pending cases, avoiding prolonged litigation costs. Despite this, Sanofi faces ongoing lawsuits in Delaware. In 2019, Sanofi recalled Zantac, and the FDA ordered its removal in 2020. Sanofi has since reintroduced Zantac with a new active ingredient, famotidine. GSK Plc (NYSE:GSK) and Pfizer Inc (NYSE:PFE) have not joined broader settlement efforts. SNY shares rose 1.02% in premarket trading.

Portfolio Pulse from Vandana Singh

April 04, 2024 | 1:16 pm

ALLR

Allarity Therapeutics has announced a 1-for-20 reverse stock split, set to take effect on April 9, 2024. This corporate action is typically undertaken to boost the stock's price in the market by reducing the number of shares available, potentially making the stock more appealing to investors.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 1:15 pm

CLSK

CleanSpark shares are trading higher amid strength in crypto-related stocks, indicating a positive market sentiment towards cryptocurrencies and companies involved in the sector.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 1:11 pm

AAPL

NVDA

TSLA

The article covers a range of topics from cryptocurrency trends, including Bitcoin's potential surge, to tech updates like iPhone 16 rumors and Tesla's EV developments. It also touches on US and world politics, market movements, and company-specific news such as Apple's stock sale by CEO Tim Cook and Nvidia's supplier investment in the US chip sector.

Portfolio Pulse from Akanksha Bakshi

April 04, 2024 | 1:11 pm

SYF

Synchrony Financial's stock (SYF) experienced a rise after Wolfe Research upgraded its rating from Underperform to Outperform and increased its price target from $36 to $50.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 1:09 pm